ACORN CAPITAL ADVISORS GP, LLC
10% Owner · OnKure Therapeutics, Inc.
Every open-market stock purchase ACORN CAPITAL ADVISORS GP, LLC has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- OKUROnKure Therapeutics, Inc.
2 purchases totalling $2.6M at an average of $1.85 per share. See all insider buying in OKUR →
Avg price paid$1.85Latest price—Market capUnknown
All reported buys
Follow new qualifying clusters involving ACORN CAPITAL ADVISORS GP, LLC or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from ACORN CAPITAL ADVISORS GP, LLC's Form 4 filings on SEC EDGAR (CIK 1813692) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.